Alibaba Health Information Technology (HKSE:00241) Research & Development : HK$781 Mil (TTM As of Mar. 2025)

View and export this data going back to 1972. Start your Free Trial

What is Alibaba Health Information Technology Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Alibaba Health Information Technology's Research & Development for the six months ended in Mar. 2025 was HK$430 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was HK$781 Mil.

Alibaba Health Information Technology Research & Development Historical Data

The historical data trend for Alibaba Health Information Technology's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alibaba Health Information Technology Research & Development Chart

Alibaba Health Information Technology Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Research & Development

Get a 7-Day Free Trial

505.24

898.63

772.04

766.26

772.05

Alibaba Health Information Technology Semi-Annual Data
	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
Research & Development	Get a 7-Day Free Trial															403.02	342.53	419.39	351.48	429.78

Alibaba Health Information Technology Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$781 Mil.

Alibaba Health Information Technology (HKSE:00241) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alibaba Health Information Technology Research & Development Related Terms

Thank you for viewing the detailed overview of Alibaba Health Information Technology's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Alibaba Health Information Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Alibaba Health Information Technology Ltd (HKSE:00241) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

ALBBY:USA ALBHF:USA TWY:Germany

Address

Guanghua Road, 65th Floor, CITIC Tower, Building 1, No.10 Courtyard, Jianwai Subdistrict, Chaoyang District, Beijing, CHN

Website

https://www.alihealth.cn

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Executives

Alibaba Group Holding Limited
Ali Jk Nutritional Products Holding Limited
Alibaba Investment Limited
Perfect Advance Holding Limited
Taobao Holding Limited
21 Cn Corporation	2201 Interest of corporation controlled by you
Pollon Internet Corporation	2201 Interest of corporation controlled by you
Uni-tech International Group Limited	2101 Beneficial owner
Chen Xiao Ying	2201 Interest of corporation controlled by you

Alibaba Health Information Technology Headlines

No Headlines